Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeloda and Radiotherapy in Locally Advanced Rectal Cancer
NCT00796718Phase 2Completed
- Sponsor
- Roche
- Start
- Oct 2008
- Primary completion
- Aug 2010
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in rectal cancer, sponsored by Roche. Started Oct 2008; status: completed.
02
Drugs
capecitabine
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00796718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00796718.